Mutual of America Capital Management LLC Lowers Position in Agilent Technologies, Inc. (NYSE:A)

Mutual of America Capital Management LLC decreased its stake in shares of Agilent Technologies, Inc. (NYSE:A) by 2.2% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 49,218 shares of the medical research company’s stock after selling 1,088 shares during the period. Mutual of America Capital Management LLC’s holdings in Agilent Technologies were worth $6,612,000 at the end of the most recent reporting period.

A number of other large investors also recently bought and sold shares of A. CKW Financial Group lifted its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares in the last quarter. Global X Japan Co. Ltd. raised its holdings in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after buying an additional 116 shares during the period. Ashton Thomas Securities LLC acquired a new position in Agilent Technologies during the third quarter valued at approximately $31,000. Hanson & Doremus Investment Management grew its stake in Agilent Technologies by 66.5% during the fourth quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock worth $35,000 after buying an additional 105 shares during the period. Finally, RPg Family Wealth Advisory LLC acquired a new stake in shares of Agilent Technologies in the third quarter worth $38,000.

Agilent Technologies Trading Down 1.2 %

A opened at $126.36 on Tuesday. The stock has a market capitalization of $36.05 billion, a PE ratio of 29.05, a P/E/G ratio of 3.59 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66. Agilent Technologies, Inc. has a 12-month low of $124.16 and a 12-month high of $155.35. The firm’s fifty day moving average price is $140.48 and its 200 day moving average price is $139.08.

Agilent Technologies (NYSE:A) last issued its quarterly earnings results on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analysts’ expectations of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, research analysts expect that Agilent Technologies, Inc. will post 5.57 EPS for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Stockholders of record on Tuesday, April 1st will be issued a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.79%. Agilent Technologies’s dividend payout ratio (DPR) is 22.76%.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of Agilent Technologies stock in a transaction dated Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on A. Citigroup lifted their target price on shares of Agilent Technologies to $165.00 and gave the company a “buy” rating in a report on Thursday, December 19th. Bank of America decreased their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research report on Friday, December 13th. JPMorgan Chase & Co. dropped their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a report on Tuesday, November 26th. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $135.00 to $145.00 in a research report on Monday, February 10th. Finally, Wells Fargo & Company lowered their price objective on shares of Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating for the company in a research report on Monday, December 9th. Seven investment analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $146.15.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.